Health Canada has not approved BPC-157 for any indication, and the August 2025 Canada Peptide advisory listed BPC-157 among seized unauthorized injectable peptide drugs
Although significant advancements have been made in understanding tinnitus and its treatment over the past two decades 3,4,5,6 , the exact mechanisms and neural patterns responsible for its onset and persistence remain unclear
Zeevalk GD, Razmpour R, Bernard LP
The zero withdrawal rate in AOD-9604 trials suggests excellent practical tolerability that extends beyond merely counting adverse events to assessing their real impact on treatment continuation
My understanding is that this should be done routinely, especially if you're on B12 in high doses, but most GP's don't know this and don't do it
CJC-1295 tells the pituitary to make more growth hormone